熱門資訊> 正文

Acurx Pharmaceuticals重新遵守纳斯达克上市规则

2025-09-03 19:42

纳比特(NA) 0
盛大科技(SDA) 0
Acurx Pharmaceuticals LLC Ordinary Shares(ACXP) 0

Acurx Pharmaceuticals (NASDAQ:ACXP) has regained compliance with Nasdaq’s minimum closing bid price and minimum stockholders' equity threshold requirements for continued listing on the exchange.
The company's common stock will remain listed and traded on the Nasdaq Stock Market.

More on Acurx Pharmaceuticals

Acurx Pharmaceuticals, Inc. (ACXP) Q2 2025 Earnings Call Transcript
Acurx signals ongoing cost controls and new trial funding avenues while advancing ibezapolstat clinical program
Acurx Pharmaceuticals files $50M mixed shelf offering
Seeking Alpha’s Quant Rating on Acurx Pharmaceuticals
Historical earnings data for Acurx Pharmaceuticals

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。